Bay Area Tumor Institute CCOP

描述(由申请人提供)： 湾区肿瘤研究所社区临床肿瘤项目(BATI-CCOP) 是由大中华区七家社区和县医院组成的联合体 奥克兰，加利福尼亚州，地区。自1979年作为CGOP创建以来，它的 1989年转为CCOP地位，该财团一直在提供 社区的癌症专家、初级保健医生和医院 拥有NCI批准和资助的临床试验计划。集成了 卫生部出版物《2010年健康人群》的目标是以少数族裔为目标，低 阿拉米达县及其主要城市奥克兰的收入和女性人口 BATI-CCOP使癌症患者和普通高危人群能够 参与SWOG、NSABP、RTOG和 齿轮。在其成就的基础上，制定长期目标和具体目标 的BATI-CCOP包括治疗试验的应计费用比 少数族裔和儿科患者的可比性CCOP、应计利润较高 比所有其他CCOP，积极的癌症控制招聘和应计 超过NCI的癌症控制研究要求，增加互动 拥有研究基地，并继续履行NCI的 CCOP将继续100%吸纳所有符合条件的儿科 该地区的肿瘤科患者占所有符合条件的癌症患者的50% 县医院，并实现少数民族和女性参与，这将 超过CCOP应计总额的75%。CCOP也将继续超过 NCI授权并保持湾区癌症预防收益的领先者 和对照试验。BATI-CCOP提供了一个成功的长期记录， 有组织、有决心的医学界，经验丰富的医生 湾区肿瘤研究人员、机构和资金支持 研究所，以及非同寻常的接触非裔美国人、西班牙裔、亚洲人、儿科医生， 服务不足，以及女性人口。

DESCRIPTION (provided by applicant): The Bay Area Tumor Institute Community Clinical Oncology Program (BATI-CCOP) is a consortium of seven community and county hospitals in the Greater Oakland, California, area. Since its creation in 1979 as a CGOP and its conversion to CCOP status in 1989, this consortium has continuously provided the community's cancer specialists, primary care physicians, and hospitals with an NCI-approved and funded clinical trials program. Integrating the goals of DHHS publication "Healthy People 2010" by targeting minority, low income and female populations in Alameda County and its main city, Oakland, the BATI-CCOP enables cancer patients and the general "at risk" population to participate in clinical and cancer control research of SWOG, NSABP, RTOG, and COG. Building on its achievements, the long-term objectives and specific aims of the BATI-CCOP include accrual to therapeutic trials at higher rates than comparable CCOP's, accrual of minority and pediatric patients at higher rates than all other CCOP's, aggressive cancer control recruitment and accrual exceeding NCI's cancer control research requirements, increased interaction with research bases, and continued fulfillment of NCI's "Terms of Cooperation." The CCOP will continue to accrue 100% of all eligible pediatric oncology patients in the region, accrue 50% of all eligible cancer patients at the county hospital, and achieve minority and female participation that will exceed 75% of the total CCOP accrual. The CCOP will also continue to exceed NCI mandates and remain the Bay Area leader in accrual to cancer prevention and control trials. The BATI-CCOP offers a successful long-term track record, an organized and committed medical community, experienced physician investigators, institutional and financial support from the Bay Area Tumor Institute, and unusual access to African American, Hispanic, Asian, pediatric, underserved, and female populations.